rs5743790

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006068.5(TLR6):​c.-64-1996A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.402 in 152,002 control chromosomes in the GnomAD database, including 13,702 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 13702 hom., cov: 32)

Consequence

TLR6
NM_006068.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0560

Publications

0 publications found
Variant links:
Genes affected
TLR6 (HGNC:16711): (toll like receptor 6) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor functionally interacts with toll-like receptor 2 to mediate cellular response to bacterial lipoproteins. A Ser249Pro polymorphism in the extracellular domain of the encoded protein may be associated with an increased of asthma is some populations.[provided by RefSeq, Jan 2011]
TLR1 (HGNC:11847): (toll like receptor 1) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.602 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TLR6NM_006068.5 linkc.-64-1996A>G intron_variant Intron 1 of 1 ENST00000508254.6 NP_006059.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TLR6ENST00000508254.6 linkc.-64-1996A>G intron_variant Intron 1 of 1 1 NM_006068.5 ENSP00000424718.2
TLR6ENST00000381950.2 linkc.-64-1996A>G intron_variant Intron 2 of 2 6 ENSP00000371376.1
TLR1ENST00000506146.5 linkc.-353+25228A>G intron_variant Intron 1 of 5 4 ENSP00000423725.1

Frequencies

GnomAD3 genomes
AF:
0.402
AC:
61090
AN:
151884
Hom.:
13682
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.608
Gnomad AMI
AF:
0.206
Gnomad AMR
AF:
0.314
Gnomad ASJ
AF:
0.298
Gnomad EAS
AF:
0.384
Gnomad SAS
AF:
0.357
Gnomad FIN
AF:
0.380
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.315
Gnomad OTH
AF:
0.358
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.402
AC:
61159
AN:
152002
Hom.:
13702
Cov.:
32
AF XY:
0.402
AC XY:
29891
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.608
AC:
25191
AN:
41440
American (AMR)
AF:
0.314
AC:
4802
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.298
AC:
1033
AN:
3464
East Asian (EAS)
AF:
0.383
AC:
1985
AN:
5186
South Asian (SAS)
AF:
0.356
AC:
1712
AN:
4812
European-Finnish (FIN)
AF:
0.380
AC:
4002
AN:
10536
Middle Eastern (MID)
AF:
0.299
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
0.315
AC:
21394
AN:
67958
Other (OTH)
AF:
0.361
AC:
764
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1754
3508
5262
7016
8770
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.366
Hom.:
2265
Bravo
AF:
0.403
Asia WGS
AF:
0.430
AC:
1494
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
6.7
DANN
Benign
0.79
PhyloP100
0.056
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5743790; hg19: chr4-38833154; API